International Patent: SMALL INTERFERING RNA COMPOUNDS FOR TARGETING FERREDOXIN 2 (FDX2) AND METHOD OF TREATING FRIEDREICH ATAXIA (FRDA)

GENEVA, Sept. 24 -- THE GENERAL HOSPITAL CORPORATION filed a patent application (US2026/019991) for “SMALL INTERFERING RNA COMPOUNDS FOR TARGETING FERREDOXIN 2 (FDX2) AND METHOD OF TREATING FRIEDREICH ATAXIA (FRDA)”. With publication no. WO/2026/198818, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....